NCCN Foundation We rely solely on donations and support from the community to fund our programs and services. Thank you for your generous support! NCCN Guidelines for Patients® Delivering unbiased expert guidance from the country’s leading doctors and cancer centers free of charge to empower all people living with cancer. Make a Donation Our supporters […]

Limited Efficacy, Manageable Safety Profile Found With TAS-117 to Treat Ovarian and Breast Cancer The highly potent and selective oral allosteric pan-v-akt murine thymoma viral oncogene homolog (Akt) inhibitor, TAS-117, showed limited clinical efficacy in treating patients with ovarian cancer harboring PIK3CA E545K mutations and in those with breast cancer harboring PIK3CA H1047R and Akt1E17K […]

‘Healthy diet, physical activity can reduce risk of cancer’ Healthy dietary habits, regular physical activity, and staying away from tobacco and drinking alcohol can help reduce the risk of cancer to a large extent, Dr. Jagadesh Chandra Bose, senior consultant, surgical oncology, Dr. Rela Institute and Medical Centre (RIMC), said on Sunday. Addressing a webinar […]

Revolution Medicines seeks to bolster case for its lead cancer drug Revolution Medicines on Saturday presented updated data to bolster the case for its lead cancer drug — designed to stop tumor growth by throttling back mutations in a common cell-signaling pathway. The drug, called RMC-4630, won’t shrink tumors very much on its own. The […]

Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer PHILADELPHIA–Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania. Changing […]

Trastuzumab Deruxtecan Sensitivity Associated With Various Levels of HER2-Expressing Gastric … Treatment with trastuzumab deruxtecan (Enhertu; DS-8201) showed promising sensitivity in patients with with HER2 moderate-, low-, and non-expressing gastric cancer, according to data from a study presented during the virtual AACR Annual Meeting 2021.1 Trastuzumab (Herceptin) and trastuzumab deruxtecan, at various concentrations, demonstrated cytostatic […]

Google Alert – cancer -horoscope Google Alert – cancer -horoscope Lung cancer risk prediction model lacks efficacy in diverse populations https://www.google.com/url?rct=j&sa=t&url=https://www.healio.com/news/primary-care/20210409/lung-cancer-risk-prediction-model-lacks-efficacy-in-diverse-populations&ct=ga&cd=CAIyHGM0YWY4ZDI3MTA1YWI2ODA6Y28uaW46ZW46SU4&usg=AFQjCNFBR3j0bFgKginlYhlOJ9raCtz0eg https://www.google.com/url?rct=j&sa=t&url=https://www.healio.com/news/primary-care/20210409/lung-cancer-risk-prediction-model-lacks-efficacy-in-diverse-populations&ct=ga&cd=CAIyHGM0YWY4ZDI3MTA1YWI2ODA6Y28uaW46ZW46SU4&usg=AFQjCNFBR3j0bFgKginlYhlOJ9raCtz0eg <div class=”article__content–header”> <div class=”article__posted-date”> <p> April 09, 2021 </p> <p> 2 min read </p> </div> </div> <div class=”mobile-trust-box”> <div class=”row”> <div class=”col-12 col-md-5 d-xl-none”> <div class=”trust-box”> <div class=”sources-disclosures”> <a class=”title collapsed” data-toggle=”collapse” data-target=”.trustbox-toggle” […]

Webinar on cancer prevention, treatment Rela Hospital will present The Hindu Wellness Series webinar on cancer prevention and treatment. The webinar will bring to the table discussions on whether cancer can be prevented, the preventable risk factors, PET/CT scan investigation, how costly treatment cancer treatment can be, and the age factor for taking up mammogram […]

Secondary Cytoreduction Followed by Chemotherapy May Improve PFS in Ovarian Cancer For patients with platinum-sensitive relapsed ovarian cancer, research found that secondary cytoreduction followed by chemotherapy was associated with statistically significant longer progression-free survival (PFS) rates when compared to chemotherapy alone, according to data published in Lancet Oncology. With these findings in mind, this cohort […]

Lung cancer risk prediction model lacks efficacy in diverse populations April 09, 2021 2 min read Source/Disclosures Disclosures: Shusted reports no relevant disclosures. Please see the study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive […]